M&A / Deals Sun Pharma to acquire Organon for $11.75bn Pharmaceutical TechnologySun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash.Read full story pharminent April 27, 2026 (Last updated: April 27, 2026) Pharmaceutical Technology Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in cash. Read full story Post navigation Previous: Sun sets out $11.75bn takeover play for OrganonNext: UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
